Anti-CSF1/M-CSF Antibody (Lacnotuzumab)
Catalog No.
F2050
Anti-CSF1/M-CSF Antibody (Lacnotuzumab)
Featured Products
Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1, which prevents CSF-1 from activating CSF-1R. Lacnotuzumab can be used in the study of pigmented villonodular synovitis.
145 kDa
Dry ice
1831128-32-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
RX1, MCS110
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P09603
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CSF1 / M-CSF
Please avoid freeze-thaw cycles.